Cardiff Oncology, Inc.
CRDF- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213037
In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Cardiff Oncology, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 58 | 1 | 60 | +3 |
| Shares | 7.93M | 120.6K | 7.70M | −106.9K (−1.4%) |
| Value | $12.2M | $186.0K | $10.8M | −$1.25M (−10.4%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Cardiff Oncology, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 98,600 | $138.0K | 0.00% |
| Two Sigma Investments, LP | 23,309 | $32.6K | 0.00% |
| FinDec Wealth Services, Inc. | 16,000 | $22.4K | 0.02% |
| Callan Capital, LLC | 13,587 | $19.0K | 0.00% |
| Jeppson Wealth Management, LLC | 12,365 | $17.3K | 0.01% |
| Belvedere Trading LLC | 10,337 | $14.5K | 0.01% |
| Belpointe Asset Management LLC | 7,000 | $9.80K | 0.00% |
| The PNC Financial Services Group, Inc. | 1,000 | $1.40K | 0.00% |
| NewSquare Capital LLC | 125 | $175 | 0.00% |
| Citigroup Inc | 100 | $140 | 0.00% |
| Sofos Investments, Inc. | 1 | $2 | 0.00% |
| Tower Research Capital LLC (TRC) | 320 | $0 | 0.00% |
| GWM Advisors LLC | 81 | $0 | 0.00% |
Sold out (10)
Institutions that held Cardiff Oncology, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| CSS LLC | 35,920 | $55.0K |
| Qube Research & Technologies Ltd | 29,996 | $46.0K |
| LPL Financial LLC | 25,784 | $40.0K |
| Jane Street Group, LLC | 20,461 | $32.0K |
| Goldman Sachs Group Inc | 14,349 | $22.0K |
| LMR Partners LLP | 13,584 | $21.0K |
| Group One Trading, L.P. | 4,619 | $7.00K |
| Laffer Tengler Investments | 21 | $32 |
| TCI Wealth Advisors, Inc. | 100 | $0 |
| Rockefeller Capital Management L.P. | 163 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Cardiff Oncology, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| ACT Capital Management, LLC | 120,600 | $186.0K |